Pulmonary Vascular
Contribute to the next guideline on pulmonary vascular disease—submit a preliminary topic proposal for a CHEST guideline. Proposals are due Friday, March 31.
START YOUR SUBMISSION »
Guidelines and expert panel reports
Perioperative Management of Antithrombotic Therapy (August 2022)
These recommendations cover the perioperative management of vitamin K antagonists, heparin bridging, antiplatelet drugs, and direct oral anti-coagulants. The recommendations also address perioperative management of patients who are undergoing minor procedures.
Antithrombotic Therapy for VTE Disease (August 2021)
This guideline and expert panel report covers aspects of antithrombotic management of venous thromboembolism (VTE) from initial management through secondary prevention and risk reduction of postthrombotic syndrome. This is the 2nd update to the 9th edition of these guidelines.
This 2021 guideline updates some of the prior recommendations in the 2016 guideline.
Therapy for Pulmonary Arterial Hypertension in Adults (March 2019)
This guideline panel conducted an updated systematic review to identify studies published after those included in the 2014 guideline in order to guide the clinician through an organized approach to management of pulmonary arterial hypertension (PAH).
Antithrombotic Therapy for Atrial Fibrillation (November 2018)
This guideline provides recommendations for antithrombotic treatment based on net clinical benefit for patients with atrial fibrillation (AF) at varying levels of stroke risk and in a number of common clinical scenarios.
Antithrombotic Therapy and Prevention of Thrombosis, 9th edition (February 2012)
This CHEST guideline series presents recommendations for the prevention, diagnosis, and treatment of thrombosis, addressing a comprehensive list of clinical conditions, including medical, surgery, orthopedic surgery, atrial fibrillation, stroke, cardiovascular disease, pregnancy, and neonates and children.
Clinician tools and materials
Podcasts
CHEST hosts a discussion with the authors upon release of a guideline, to add context and commentary to the issues and challenges facing clinicians.
Antithrombotic Therapy Recommendations for VTE Disease (August 2021)
Moderator: Gretchen Winter, MD
Participant: Lisa K. Moores, MD
Antithrombotic Therapy for VTE Disease: CHEST Guideline (February 2016)
Moderator: Ian T. Nathanson, MD, FCCP
Participants: Clive Kearon, MD, PhD; COL Lisa K. Moores, MC, USA, FCCP
Pulmonary Arterial Hypertension: New CHEST Guidelines and New CDC Report (August 2014)
Moderator: D. Kyle Hogarth, MD, FCCP
Participants: Terence K. Trow, MD, FCCP; Mary G. George, MD; Anna R. Hemnes, MD